JPS6059883B2
(ja)
|
1978-05-08 |
1985-12-27 |
北興化学工業株式会社 |
農園芸用殺菌剤
|
GB2183243B
(en)
|
1985-10-09 |
1990-01-24 |
Nippon Oil Co Ltd |
Process for preparing oil-soluble nitrogen-containing compounds
|
AU3752589A
(en)
|
1988-05-16 |
1989-12-12 |
Georgia State University Research Foundation, Inc. |
Nucleic acid interacting unfused heteropolycyclic compounds
|
LU87304A1
(fr)
|
1988-07-29 |
1990-02-07 |
Oreal |
Nouveaux derives d'ureylene triamino-2,4,6 pyrimidine oxyde-3,leur preparation et leur utilisation en cosmetique et dermopharmacie
|
JPH02282251A
(ja)
|
1989-04-24 |
1990-11-19 |
Fuji Photo Film Co Ltd |
ハロゲン化銀カラー写真感光材料
|
DE3922735A1
(de)
|
1989-07-11 |
1991-01-24 |
Hoechst Ag |
Aminopyrimidin-derivate, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung als fungizide
|
DE4034762A1
(de)
|
1990-11-02 |
1992-05-07 |
Hoechst Ag |
Pyridylpyrimidine, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung als fungizide
|
GB2263639A
(en)
|
1992-01-28 |
1993-08-04 |
Merck & Co Inc |
Substituted pyrimidinones as neurotensin antagonists
|
HU209678B
(en)
|
1992-06-09 |
1994-10-28 |
Richter Gedeon Vegyeszet |
Process for producing biologically active eburnamenin-14-carbonyl-amino derivatives and pharmaceutical compositions containing them
|
DK72693D0
(da)
|
1993-06-18 |
1993-06-18 |
Lundbeck & Co As H |
Compounds
|
CA2133355A1
(en)
|
1993-10-04 |
1995-04-05 |
Itaru Nitta |
Method for producing polypeptide
|
WO1998006709A1
(en)
|
1996-08-14 |
1998-02-19 |
Takeda Chemical Industries, Ltd. |
Cyclic urea compounds, their production and use as herbicides
|
DE19642863A1
(de)
|
1996-10-17 |
1998-04-23 |
Bayer Ag |
Amide
|
US6117973A
(en)
|
1997-02-24 |
2000-09-12 |
Georgia Tech Research Corp. |
PNA monomers with electron donor or acceptor
|
JPH11158073A
(ja)
|
1997-09-26 |
1999-06-15 |
Takeda Chem Ind Ltd |
アデノシンa3拮抗剤
|
JPH11282132A
(ja)
|
1998-03-27 |
1999-10-15 |
Fuji Photo Film Co Ltd |
ハロゲン化銀写真感光材料の処理方法
|
JP2000072695A
(ja)
|
1998-08-24 |
2000-03-07 |
Sumitomo Pharmaceut Co Ltd |
環状化合物
|
JP2000075449A
(ja)
|
1998-08-31 |
2000-03-14 |
Fuji Photo Film Co Ltd |
ハロゲン化銀写真感光材料の現像方法
|
JP2003508509A
(ja)
|
1999-09-04 |
2003-03-04 |
アストラゼネカ アクチボラグ |
ピルビン酸デヒドロゲナーゼの阻害剤としてのアミド
|
EP1218003A4
(en)
|
1999-09-13 |
2004-02-11 |
David M Swope |
COMPOSITION AND METHOD FOR REDUCING NEUROLOGICAL SYMPTOMATOLOGY
|
US6906067B2
(en)
|
1999-12-28 |
2005-06-14 |
Bristol-Myers Squibb Company |
N-heterocyclic inhibitors of TNF-α expression
|
MXPA03000032A
(es)
|
2000-06-29 |
2003-08-19 |
Neurosearch As |
Uso de derivados de oxindol 3-sustituidos como moduladores de los canales de potasio kcnq.
|
EP1578341A4
(en)
|
2000-10-11 |
2005-09-28 |
Tularik Inc |
MODULATION OF THE CCR4 FUNCTION
|
CA2430951A1
(en)
|
2000-12-07 |
2002-06-13 |
Cv Therapeutics, Inc. |
Substituted 1, 3, 5-triazines and pyrimidines as abca-1 elevating compounds against coronary artery disease or atherosclerosis
|
IL156595A0
(en)
|
2001-01-16 |
2004-01-04 |
Astrazeneca Ab |
Therapeutic heterocyclic compounds
|
JP2004517129A
(ja)
|
2001-01-16 |
2004-06-10 |
アストラゼネカ・アクチエボラーグ |
治療用クロモン化合物
|
EP1353915A2
(en)
|
2001-01-16 |
2003-10-22 |
AstraZeneca AB |
Therapeutic chroman compounds
|
WO2002064096A2
(en)
|
2001-02-16 |
2002-08-22 |
Tularik Inc. |
Methods of using pyrimidine-based antiviral agents
|
CN101519386A
(zh)
*
|
2001-04-16 |
2009-09-02 |
田边三菱制药株式会社 |
高传导率钙-活化k通道开启剂
|
EP1270551A1
(en)
|
2001-06-26 |
2003-01-02 |
Aventis Pharma Deutschland GmbH |
Urea derivatives with antiproteolytic activity
|
US7378432B2
(en)
|
2001-09-14 |
2008-05-27 |
Tel Aviv University Future Technology Development L.P. |
Glycogen synthase kinase-3 inhibitors
|
US7012077B2
(en)
|
2001-12-20 |
2006-03-14 |
Hoffmann-La Roche Inc. |
Substituted cyclohexane derivatives
|
AU2003212634A1
(en)
|
2002-03-11 |
2003-09-22 |
Zetiq Technologies Ltd. |
Compounds useful in the treatment of cancer
|
MY141867A
(en)
|
2002-06-20 |
2010-07-16 |
Vertex Pharma |
Substituted pyrimidines useful as protein kinase inhibitors
|
US20040082627A1
(en)
|
2002-06-21 |
2004-04-29 |
Darrow James W. |
Certain aromatic monocycles as kinase modulators
|
JP2006500372A
(ja)
|
2002-08-19 |
2006-01-05 |
グラクソ グループ リミテッド |
選択的cox−2阻害物質としてのピリミジン誘導体
|
CN1671639A
(zh)
|
2002-08-23 |
2005-09-21 |
康涅狄格大学 |
新型联苯大麻素和类似联苯的大麻素
|
GB0311201D0
(en)
|
2003-05-15 |
2003-06-18 |
Merck Sharp & Dohme |
Therapeutic agents
|
US7589092B2
(en)
|
2003-06-20 |
2009-09-15 |
Koronis Pharmaceuticals, Incorporated |
Prodrugs of heteroaryl compounds
|
US7790736B2
(en)
|
2003-08-13 |
2010-09-07 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors
|
WO2005035507A2
(en)
|
2003-10-10 |
2005-04-21 |
Bayer Pharmaceuticals Corporation |
4-aminopyrimidine derivatives for treatment of hyperproliferative disorders
|
WO2005037826A1
(en)
|
2003-10-17 |
2005-04-28 |
Incyte Corporation |
Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases
|
BRPI0416853A
(pt)
|
2003-11-24 |
2007-02-13 |
Hoffmann La Roche |
pirazolila e imidazolila pirimidinas
|
TW200528101A
(en)
|
2004-02-03 |
2005-09-01 |
Astrazeneca Ab |
Chemical compounds
|
CN1976905A
(zh)
|
2004-03-30 |
2007-06-06 |
大正制药株式会社 |
嘧啶衍生物以及与其应用有关的治疗方法
|
CA2563895C
(en)
|
2004-04-13 |
2012-10-16 |
Synta Pharmaceuticals Corp. |
Disalt inhibitors of il-12 production
|
SE0401971D0
(sv)
|
2004-08-02 |
2004-08-02 |
Astrazeneca Ab |
Piperidne derivatives
|
CA2581454A1
(en)
|
2004-09-23 |
2006-03-30 |
Reddy Us Therapeutics, Inc. |
Novel pyrimidine compounds, process for their preparation and compositions containing them
|
GB0422556D0
(en)
|
2004-10-11 |
2004-11-10 |
Syngenta Participations Ag |
Novel insecticides
|
EP1655283A1
(en)
|
2004-11-08 |
2006-05-10 |
Evotec OAI AG |
11beta-HSD1 Inhibitors
|
TW200628463A
(en)
|
2004-11-10 |
2006-08-16 |
Synta Pharmaceuticals Corp |
Heteroaryl compounds
|
WO2006065590A2
(en)
|
2004-12-16 |
2006-06-22 |
Xtl Biopharmaceuticals Inc. |
Pyridine and pyrimidine antiviral compositions
|
AU2005322855B2
(en)
|
2004-12-30 |
2012-09-20 |
Exelixis, Inc. |
Pyrimidine derivatives as kinase modulators and method of use
|
US20080249091A1
(en)
|
2005-01-19 |
2008-10-09 |
Benjamin Pelcman |
Indoles Useful in the Treatment of Inflammation
|
WO2006077412A1
(en)
|
2005-01-19 |
2006-07-27 |
Biolipox Ab |
Thienopyrroles useful in the treatment of inflammation
|
US20100197687A1
(en)
|
2005-01-19 |
2010-08-05 |
Benjamin Pelcman |
Indoles Useful in the Treatment of Inflammation
|
CA2594773A1
(en)
|
2005-01-19 |
2006-07-27 |
Biolipox Ab |
Indoles useful in the treatment of inflammation
|
CN101142185A
(zh)
|
2005-01-19 |
2008-03-12 |
比奥里波克斯公司 |
用于炎症治疗的吲哚
|
US20070135437A1
(en)
|
2005-03-04 |
2007-06-14 |
Alsgen, Inc. |
Modulation of neurodegenerative diseases
|
CA2601527A1
(en)
|
2005-03-14 |
2006-09-21 |
Neurosearch A/S |
Potassium channel modulating agents and their medical use
|
CN101115736A
(zh)
*
|
2005-03-14 |
2008-01-30 |
神经研究公司 |
钾通道调节剂和它们的医药用途
|
US20060156481A1
(en)
|
2005-03-22 |
2006-07-20 |
The Procter & Gamble Company |
Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof
|
WO2006100212A1
(en)
*
|
2005-03-22 |
2006-09-28 |
Neurosearch A/S |
Pyrazolyl-pyrimidines as potassium channel modulating agents and their medical use
|
US20090036475A1
(en)
|
2005-03-22 |
2009-02-05 |
Neurosearch A/S |
Pyrazolyl-Pyrimidines as Potassium Channel Modulating Agents and Their Medical Use
|
DE102005025315A1
(de)
|
2005-06-02 |
2006-12-14 |
Merck Patent Gmbh |
Ionische Flüssigkeiten mit niedriger Viskosität
|
CA2612227C
(en)
|
2005-06-14 |
2014-04-22 |
Taigen Biotechnology Co., Ltd. |
Pyrimidine compounds
|
ATE489370T1
(de)
|
2005-06-14 |
2010-12-15 |
Schering Corp |
Herstellung und verwendung von verbindungen als aspartylproteasehemmer
|
US8193206B2
(en)
|
2005-06-14 |
2012-06-05 |
Taigen Biotechnology Co., Ltd. |
Pyrimidine compounds
|
KR20080033450A
(ko)
|
2005-07-30 |
2008-04-16 |
아스트라제네카 아베 |
증식성 질환의 치료에 사용하기 위한 이미다졸릴-피리미딘화합물
|
DE102005043165A1
(de)
|
2005-09-12 |
2007-03-22 |
Merck Patent Gmbh |
Metallkomplexe
|
JP2007091649A
(ja)
|
2005-09-29 |
2007-04-12 |
Taisho Pharmaceut Co Ltd |
ピリミジン誘導体及びその使用に関連する治療方法
|
GB0520657D0
(en)
|
2005-10-11 |
2005-11-16 |
Ludwig Inst Cancer Res |
Pharmaceutical compounds
|
FR2892859B1
(fr)
|
2005-10-27 |
2008-06-06 |
Commissariat Energie Atomique |
Procede de greffage de molecules d'interet sur des surfaces inorganiques, surfaces obtenues et applications
|
US8642278B2
(en)
|
2005-11-22 |
2014-02-04 |
University Of South Florida |
Inhibition of cell proliferation
|
RU2008128452A
(ru)
|
2005-12-12 |
2010-01-20 |
Дженелабс Текнолоджис, Инк. (Us) |
Соединения n-(6-членных арил)-амидов, фармацевтическая композиция с противовирусной активностью на их основе, способ лечения или профилактики вирусной инфекции с их помощью и способ их получения
|
RU2008128453A
(ru)
|
2005-12-12 |
2010-01-20 |
Дженелабс Текнолоджис, Инк. (Us) |
Соединение n-(5-членных арил)-амидов, фармацевтическая композиция с противовирусной активностью на их основе, способ лечения или профилактики вирусной инфекции с их помощью и способ их получения
|
JP2009519995A
(ja)
|
2005-12-20 |
2009-05-21 |
ノイロサーチ アクティーゼルスカブ |
呼吸器疾患の治療のためのカリウムチャンネル調節剤としての2−ピリジン−2−イル−キナゾリン誘導体
|
CN102943106A
(zh)
|
2006-03-13 |
2013-02-27 |
珀金埃尔默健康科学股份有限公司 |
用于质谱法检测的底物和内标
|
US20090318507A2
(en)
|
2006-05-02 |
2009-12-24 |
Chris Rundfeldt |
Potassium Channel Activators for the Prevention and Treatment of Dystonia and Dystonia Like Symptoms
|
WO2008005538A2
(en)
|
2006-07-05 |
2008-01-10 |
Exelixis, Inc. |
Methods of using igf1r and abl kinase modulators
|
FR2904316B1
(fr)
|
2006-07-31 |
2008-09-05 |
Sanofi Aventis Sa |
Derives de n-(amino-heteroaryl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique.
|
CA2659391A1
(en)
|
2006-08-03 |
2008-02-07 |
Prosensa Technologies B.V. |
Antibiotic composition
|
US20110144140A1
(en)
|
2006-09-07 |
2011-06-16 |
Eriksen Birgitte L |
Pyridinyl-pyrimidine derivatives useful as potassium channel modulating agents
|
US8222262B2
(en)
|
2006-10-03 |
2012-07-17 |
Neurosearch A/S |
Indazolyl derivatives useful as potassium channel modulating agents
|
WO2008052861A2
(de)
|
2006-10-10 |
2008-05-08 |
Proionic Production Of Ionic Substances Gmbh & Co Keg |
Verfahren zur herstellung von 1,3 -hetero-aromatischen carbonaten
|
JP2010510246A
(ja)
|
2006-11-21 |
2010-04-02 |
スミスクライン ビーチャム コーポレーション |
アミド抗ウイルス化合物
|
US20100234341A1
(en)
|
2006-12-04 |
2010-09-16 |
Marion Lanier |
Substituted pyrimidines as adenosine receptor antagonists
|
GB0701426D0
(en)
|
2007-01-25 |
2007-03-07 |
Univ Sheffield |
Compounds and their use
|
EP2118087B1
(en)
|
2007-02-06 |
2012-03-28 |
Novartis AG |
Pi 3-kinase inhibitors and methods of their use
|
US8940900B2
(en)
|
2007-02-28 |
2015-01-27 |
Advinus Therapeutics Private Limited |
2,2,2-tri-substituted acetamide derivatives as glucokinase activators, their process and pharmaceutical application
|
WO2008110891A2
(en)
|
2007-03-09 |
2008-09-18 |
Orchid Research Laboratories Limited, |
New heterocyclic compounds
|
NZ579248A
(en)
|
2007-03-28 |
2011-08-26 |
Neurosearch As |
Purinyl derivatives and their use as potassium channel modulators
|
EP2132208A1
(en)
|
2007-03-28 |
2009-12-16 |
NeuroSearch AS |
Purinyl derivatives and their use as potassium channel modulators
|
WO2008125811A1
(en)
|
2007-04-11 |
2008-10-23 |
Astrazeneca Ab |
N-[HETEROARYLCARBONYL]-S-THIENYL-L-ALANINE DERIVATIVES AS α5β1 ANTAGONISTS
|
US8633186B2
(en)
|
2007-06-08 |
2014-01-21 |
Senomyx Inc. |
Modulation of chemosensory receptors and ligands associated therewith
|
US7928111B2
(en)
|
2007-06-08 |
2011-04-19 |
Senomyx, Inc. |
Compounds including substituted thienopyrimidinone derivatives as ligands for modulating chemosensory receptors
|
WO2009017838A2
(en)
|
2007-08-01 |
2009-02-05 |
Exelixis, Inc. |
Combinations of jak-2 inhibitors and other agents
|
JP5111039B2
(ja)
|
2007-09-27 |
2012-12-26 |
富士フイルム株式会社 |
重合性化合物、重合開始剤、および染料を含有する光硬化性組成物
|
US9089572B2
(en)
|
2008-01-17 |
2015-07-28 |
California Institute Of Technology |
Inhibitors of p97
|
ES2655305T3
(es)
|
2008-02-08 |
2018-02-19 |
Shiseido Company, Ltd. |
Agente para blanqueamiento de la piel
|
WO2009105881A1
(en)
|
2008-02-28 |
2009-09-03 |
Saint Mary's University |
Ionic liquids comprising ligands containing positively charged heterocyclic ring useful as catalyst and for metal extractions
|
WO2009120094A2
(en)
|
2008-03-27 |
2009-10-01 |
Auckland Uniservices Limited |
Substituted pyrimidines and triazines and their use in cancer therapy
|
US8575338B2
(en)
|
2008-04-09 |
2013-11-05 |
Mitsubishi Tanabe Pharma Corporation |
Pyrimidine, pyridine and triazine derivatives as maxi-K channel openers
|
EP2279192B1
(en)
|
2008-05-28 |
2013-10-30 |
Merck Patent GmbH |
Ionic liquids
|
CA2727073A1
(en)
|
2008-06-11 |
2009-12-17 |
Astrazeneca Ab |
Tricyclic 2,4-diamin0-l,3,5-triazine derivatives useful for the treatment of cancer and myeloproliferative disorders
|
US9447049B2
(en)
|
2010-03-01 |
2016-09-20 |
University Of Tennessee Research Foundation |
Compounds for treatment of cancer
|
US8822513B2
(en)
|
2010-03-01 |
2014-09-02 |
Gtx, Inc. |
Compounds for treatment of cancer
|
DE102008031480A1
(de)
|
2008-07-03 |
2010-01-07 |
Merck Patent Gmbh |
Salze enthaltend ein Pyrimidincarbonsäure-Derivat
|
GB0815369D0
(en)
|
2008-08-22 |
2008-10-01 |
Summit Corp Plc |
Compounds for treatment of duchenne muscular dystrophy
|
CN102177154A
(zh)
*
|
2008-09-02 |
2011-09-07 |
神经研究公司 |
吡唑基-嘧啶衍生物及其作为钾通道调节剂的应用
|
CN101684098A
(zh)
|
2008-09-24 |
2010-03-31 |
中国科学院上海药物研究所 |
一类5-脂氧酶抑制剂及其制备方法、药物组合物和应用
|
US8268838B2
(en)
|
2008-09-26 |
2012-09-18 |
Neurosearch A/S |
Substituted purinyl-pyrazole derivatives and their use as potassium channel modulators
|
WO2010048149A2
(en)
|
2008-10-20 |
2010-04-29 |
Kalypsys, Inc. |
Heterocyclic modulators of gpr119 for treatment of disease
|
GB2465405A
(en)
|
2008-11-10 |
2010-05-19 |
Univ Basel |
Triazine, pyrimidine and pyridine analogues and their use in therapy
|
WO2010068863A2
(en)
|
2008-12-12 |
2010-06-17 |
Cystic Fibrosis Foundation Therapeutics, Inc. |
Pyrimidine compounds and methods of making and using same
|
AR074870A1
(es)
|
2008-12-24 |
2011-02-16 |
Palau Pharma Sa |
Derivados de pirazolo (1,5-a ) piridina
|
WO2010120994A2
(en)
|
2009-04-17 |
2010-10-21 |
Wyeth Llc |
Ureidoaryl-and carbamoylaryl-morpholino- pyrimidine compounds, their use as mtor kinase and pi3 kinase inhibitors, and their synthesis
|
EP2440559B1
(en)
|
2009-05-05 |
2018-01-10 |
Dana-Farber Cancer Institute, Inc. |
Egfr inhibitors and methods of treating disorders
|
CA2766033C
(en)
|
2009-06-25 |
2016-09-20 |
Alkermes, Inc. |
Prodrugs of nh-acidic compounds
|
WO2010151797A2
(en)
|
2009-06-26 |
2010-12-29 |
University Of Massachusetts |
Compounds for modulating rna binding proteins and uses therefor
|
HUE027263T2
(en)
|
2009-07-08 |
2016-10-28 |
Baltic Bio Ab |
1,2,4-thiazolidin-3-one derivatives and their use in the treatment of cancer
|
WO2011008931A2
(en)
|
2009-07-15 |
2011-01-20 |
Cystic Fibrosis Foundation Therapeutics, Inc. |
Arylpyrimidine compounds and combination therapy comprising same for treating cystic fibrosis & related disorders
|
AR077999A1
(es)
|
2009-09-02 |
2011-10-05 |
Vifor Int Ag |
Antagonistas de pirimidin y triazin-hepcidina
|
EP2473498A1
(en)
|
2009-09-04 |
2012-07-11 |
Bayer Pharma Aktiengesellschaft |
Substituted aminoquinoxalines as tyrosine threonine kinase inhibitors
|
TW201111379A
(en)
|
2009-09-09 |
2011-04-01 |
Vifor Int Ag |
Novel thiazole-and oxazole-hepcidine-antagonists
|
US9181414B2
(en)
|
2009-11-13 |
2015-11-10 |
Plastipak Packaging, Inc. |
Oxygen scavengers, compositions comprising the scavengers, and articles made from the compositions
|
FR2954317B1
(fr)
|
2009-12-23 |
2012-01-27 |
Galderma Res & Dev |
Nouveaux derives phenoliques, et leur utilisation pharmaceutique ou cosmetique
|
AT509266B1
(de)
|
2009-12-28 |
2014-07-15 |
Tech Universität Wien |
Substituierte pyridine und pyrimidine
|
EP3064204A1
(en)
|
2010-03-01 |
2016-09-07 |
GTx, Inc. |
Compounds for treatment of cancer
|
BR112012029026A2
(pt)
|
2010-05-13 |
2016-08-02 |
Amgen Inc |
composto heretocíclicos de nitrogênio úteis como inbidores pde10
|
WO2012009258A2
(en)
|
2010-07-13 |
2012-01-19 |
Edward Roberts |
Peptidomimetic galanin receptor modulators
|
KR20120018236A
(ko)
|
2010-07-23 |
2012-03-02 |
현대약품 주식회사 |
치환된 피리미디닐 유도체 및 이의 제조방법
|
WO2012016133A2
(en)
|
2010-07-29 |
2012-02-02 |
President And Fellows Of Harvard College |
Ros1 kinase inhibitors for the treatment of glioblastoma and other p53-deficient cancers
|
CA2806634A1
(en)
|
2010-08-20 |
2012-02-23 |
Gruenenthal Gmbh |
Substituted cyclic carboxamide and urea derivatives as ligands of the vanilloid receptor
|
CN103189357B
(zh)
*
|
2010-08-27 |
2015-11-25 |
格吕伦塔尔有限公司 |
作为kcnq2/3调节剂的取代的2-氧代-和2-硫代-二氢喹啉-3-甲酰胺
|
JP2013542562A
(ja)
|
2010-09-30 |
2013-11-21 |
ビーエーエスエフ ソシエタス・ヨーロピア |
電解質用添加剤
|
EP2630136A1
(en)
|
2010-10-21 |
2013-08-28 |
Universität des Saarlandes |
Selective cyp11b1 inhibitors for the treatment of cortisol dependent diseases
|
EP2651405A2
(en)
|
2010-12-14 |
2013-10-23 |
Electrophoretics Limited |
Casein kinase 1 (ck1 ) inhibitors
|
WO2012088438A1
(en)
|
2010-12-22 |
2012-06-28 |
Eutropics Pharmaceuticals, Inc. |
Compositions and methods useful for treating diseases
|
WO2012109343A2
(en)
|
2011-02-08 |
2012-08-16 |
President And Fellows Of Harvard College |
Iron complexes and methods for polymerization
|
WO2012129562A2
(en)
|
2011-03-24 |
2012-09-27 |
The Scripps Research Institute |
Compounds and methods for inducing chondrogenesis
|
CN102731492B
(zh)
|
2011-03-30 |
2016-06-29 |
江苏恒瑞医药股份有限公司 |
环己烷类衍生物、其制备方法及其在医药上的应用
|
WO2012154880A1
(en)
|
2011-05-09 |
2012-11-15 |
Proteostasis Therapeutics, Inc. |
Proteostasis regulators for treating cystic fibrosis and other protein misfolding diseases
|
DK2707101T3
(da)
|
2011-05-12 |
2019-05-13 |
Proteostasis Therapeutics Inc |
Proteostaseregulatorer
|
SG195086A1
(en)
|
2011-05-31 |
2013-12-30 |
Merck Patent Gmbh |
Compounds containing hydrido-tricyano-borate anions
|
WO2012167171A2
(en)
|
2011-06-03 |
2012-12-06 |
Massachusetts Institute Of Technology |
Z-selective ring-closing metathesis reactions
|
US9321727B2
(en)
|
2011-06-10 |
2016-04-26 |
Hoffmann-La Roche Inc. |
Pyridine derivatives as agonists of the CB2 receptor
|
JP2013020223A
(ja)
|
2011-06-17 |
2013-01-31 |
Fujifilm Corp |
高分子フィルム、セルロースエステルフィルム、偏光板、及び液晶表示装置
|
AU2012302022A1
(en)
|
2011-08-29 |
2014-03-13 |
Ptc Therapeutics, Inc. |
Antibacterial compounds and methods for use
|
JP5741850B2
(ja)
|
2011-09-13 |
2015-07-01 |
コニカミノルタ株式会社 |
光学フィルム、それを含む偏光板および液晶表示装置
|
JP5857713B2
(ja)
|
2011-12-15 |
2016-02-10 |
コニカミノルタ株式会社 |
光学フィルム、偏光板、及び液晶表示装置
|
WO2013120040A1
(en)
|
2012-02-10 |
2013-08-15 |
Children's Medical Center Corporation |
Targeted pathway inhibition to improve muscle structure, function and activity in muscular dystrophy
|
DE102012006896A1
(de)
|
2012-04-05 |
2013-10-10 |
Merck Patent Gmbh |
Silikate mit organischen Kationen
|
US9013997B2
(en)
|
2012-06-01 |
2015-04-21 |
Broadcom Corporation |
System for performing distributed data cut-through
|
FR2992317B1
(fr)
|
2012-06-22 |
2016-05-13 |
Diverchim |
Procede de preparation de peptides chiraux
|
CA2880299A1
(en)
|
2012-07-27 |
2014-01-30 |
Bial - Portela & Ca, S.A. |
Process for the synthesis of substituted urea compounds
|
US20150246024A1
(en)
|
2012-08-20 |
2015-09-03 |
The University Of Chicago |
Methods and compositions for inhibiting gram positive bacteria
|
WO2014031872A2
(en)
|
2012-08-23 |
2014-02-27 |
The Broad Institute, Inc. |
Small molecule inhibitors for treating parasitic infections
|
SG11201501620QA
(en)
|
2012-09-18 |
2015-04-29 |
Heptares Therapeutics Ltd |
Bicyclic aza compounds as muscarinic m1 receptor agonists
|
DE102012021452A1
(de)
|
2012-10-31 |
2014-04-30 |
Merck Patent Gmbh |
Salze mit Trihydroperfluoralkoxybutansulfonat- oder Trihydroperfluoralkoxypropansulfonat-Anion
|
CA2890906A1
(en)
|
2012-11-16 |
2014-05-22 |
The Regents Of The University Of California |
Pictet-spengler ligation for protein chemical modification
|
ES2469290B2
(es)
|
2012-12-17 |
2015-01-26 |
Ocupharm Diagnostics S.L. |
Mejora en la aplicación tópica de fármacos oculares mediante la administración de nucleótidos
|
US9499762B2
(en)
|
2012-12-21 |
2016-11-22 |
Afton Chemical Corporation |
Additive compositions with a friction modifier and a detergent
|
US9279094B2
(en)
|
2012-12-21 |
2016-03-08 |
Afton Chemical Corporation |
Friction modifiers for use in lubricating oil compositions
|
JP6450323B2
(ja)
|
2013-01-07 |
2019-01-09 |
ユニバーシティ オブ サザン カリフォルニア |
デオキシウリジントリホスファターゼ阻害剤
|
WO2014108487A1
(en)
|
2013-01-10 |
2014-07-17 |
Universite D'aix-Marseille |
P-stereogenic chiral precursor of chiral ligands and use thereof
|
US9487472B2
(en)
|
2013-02-26 |
2016-11-08 |
President And Fellows Of Harvard College |
Synthesis of acyclic and cyclic amines using iron-catalyzed nitrene group transfer
|
EP3985003B1
(en)
|
2013-03-12 |
2023-08-09 |
Vertex Pharmaceuticals Incorporated |
Dna-pk inhibitors
|
EP2981522A4
(en)
|
2013-04-05 |
2016-08-31 |
Salk Inst For Biological Studi |
ANTAGONISTS OF PPAR
|
WO2015000548A1
(de)
|
2013-07-02 |
2015-01-08 |
Merck Patent Gmbh |
Organische elektrolumineszenzvorrichtung
|
WO2015003360A2
(en)
*
|
2013-07-11 |
2015-01-15 |
Agios Pharmaceuticals, Inc. |
Therapeutically active compounds and their methods of use
|
AU2014295000A1
(en)
|
2013-07-25 |
2016-02-18 |
Fondazione Telethon |
Inhibitors of FAPP2 and uses thereof
|
US9701635B2
(en)
|
2013-07-26 |
2017-07-11 |
The Regents Of The University Of California |
C-H fluorination of heterocycles with silver (II) fluoride
|
WO2015031725A1
(en)
|
2013-08-30 |
2015-03-05 |
President And Fellows Of Harvard College |
Transition metal-catalyzed imidation of arenes
|
DE102013016324A1
(de)
|
2013-10-04 |
2015-04-09 |
Merck Patent Gmbh |
Perfluoralkylfluor- oder Perfluoralkylchlorgermanate
|
BR112016008632A8
(pt)
|
2013-10-21 |
2020-03-17 |
Merck Patent Gmbh |
compostos de heteroarila como inibidores de btk, seus usos, e composição farmacêutica
|
WO2015069752A1
(en)
|
2013-11-05 |
2015-05-14 |
The Regents Of The University Of California |
Acetylcholine binding protein ligands, cooperative nachr modulators and methods for making and using
|
CN103626741A
(zh)
|
2013-11-26 |
2014-03-12 |
苏州大学 |
具有腺苷受体拮抗剂活性的杂环氨基嘧啶化合物
|
ES2906062T3
(es)
|
2013-11-29 |
2022-04-13 |
Proionic Gmbh |
Procedimiento para la unión de un material termoplástico por medio de radiación de microondas
|
WO2015084936A1
(en)
|
2013-12-04 |
2015-06-11 |
The Scripps Research Institute |
Novel compounds as jnk kinase inhibitors
|
PT3126352T
(pt)
|
2014-04-04 |
2018-12-27 |
Syros Pharmaceuticals Inc |
Inibidores da quinase dependente de ciclina 7 (cdk7)
|
US10308648B2
(en)
|
2014-10-16 |
2019-06-04 |
Syros Pharmaceuticals, Inc. |
Inhibitors of cyclin-dependent kinase 7 (CDK7)
|
US10227333B2
(en)
|
2015-02-11 |
2019-03-12 |
Curtana Pharmaceuticals, Inc. |
Inhibition of OLIG2 activity
|
GB201502412D0
(en)
|
2015-02-13 |
2015-04-01 |
Canbex Therapeutics Ltd |
Therapeutic use
|
US10980755B2
(en)
|
2015-09-10 |
2021-04-20 |
The Regents Of The University Of California |
LRH-1 modulators
|
US20170299609A1
(en)
|
2016-04-18 |
2017-10-19 |
Wright State University |
Treatment of amyotrophic lateral sclerosis with sk channel activators
|
US10774064B2
(en)
|
2016-06-02 |
2020-09-15 |
Cadent Therapeutics, Inc. |
Potassium channel modulators
|
US20170355708A1
(en)
|
2016-06-09 |
2017-12-14 |
Cadent Therapeutics, Inc. |
Potassium channel modulators
|
WO2018136918A1
(en)
|
2017-01-23 |
2018-07-26 |
Cadent Therapeutics, Inc. |
Methods for the treatment of tremors by positive modulation of sk channels
|
AR110770A1
(es)
*
|
2017-01-23 |
2019-05-02 |
Cadent Therapeutics Inc |
Moduladores del canal de potasio
|